+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Pharmacogenomics Market by Product (Consumables, Kits & Reagents, Services), Technology (DNA Sequencing, Electrophoresis, Mass Spectrometry), Indication, Application - Forecast 2024-2030- Product Image
Global Pharmacogenomics Market by Product (Consumables, Kits & Reagents, Services), Technology (DNA Sequencing, Electrophoresis, Mass Spectrometry), Indication, Application - Forecast 2024-2030- Product Image
Sale

Global Pharmacogenomics Market by Product (Consumables, Kits & Reagents, Services), Technology (DNA Sequencing, Electrophoresis, Mass Spectrometry), Indication, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5716074
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmacogenomics Market size was estimated at USD 4.06 billion in 2023, USD 4.48 billion in 2024, and is expected to grow at a CAGR of 10.54% to reach USD 8.20 billion by 2030.

The pharmacogenomics market encompasses the study of genetic variations influencing an individual's response to drugs. Pharmacogenomics combines pharmacology, genomics, and personalized medicine to tailor pharmaceutical treatments to patient's genetic makeup, enhancing efficacy and minimizing adverse effects. Innovations in DNA sequencing and analysis have propelled pharmacogenomics forward. A shift towards tailored therapeutic approaches has heightened the need for pharmacogenomic testing. Rising investment in healthcare, particularly in precision medicine, is a crucial growth driver in the market. However, handling genetic information raises privacy issues and ethical questions.

The expense associated with pharmacogenomic testing and analysis can be prohibitive for widespread adoption, challenging the market growth. Moreover, Integrating pharmacogenomic data in drug development can enhance drug efficacy and safety, reducing time and costs. Leveraging AI to predict patient responses to drugs can refine personalized treatment approaches, creating opportunities for market growth.

Regional Insights

In the U.S., pharmacogenomics has integrated deeply into clinical practices, propelled mainly by extensive research, substantial investments, and supportive regulatory policies. Initiatives by the regulatory authorities toward personalized medicine and the presence of leading biopharmaceutical companies contribute to vibrant market dynamics in the Americas region. The European region is advancing in pharmacogenomics, backed by collaborative projects and funding under Horizon Europe. Initiatives such as the European Pharmacogenetics Implementation Consortium (Eu-PIC) aim to harmonize regional clinical practices. Pharmacogenomics is gaining traction with the Middle East's growing healthcare expenditure and focus on healthcare infrastructure.

Countries such as Saudi Arabia and the UAE are investing in genetic research and biotechnology, foreseeing pharmacogenomics as a crucial component of their healthcare strategy. In the APAC region, major countries such as China, India, and Japan are witnessing significant growth driven by government initiatives in biotechnology and healthcare reform. The country's massive genomic studies and investments in genetic testing companies underline a strategic move towards personalized medicine, meeting a growing consumer demand for customized healthcare solutions.

Market Trends by Segment

  • Technology: Advances in Polymerase Chain Reaction technique
  • Application: Diverse applications of pharmacogenomics across industries

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

SOPHiA GENETICS Announces Expansion of Work with CHU de Nîmes

SOPHiA GENETICS, a pioneer in cloud-native software for data-driven medicine, announces the extension of its collaboration with CHU de Nîmes, a regional and university hospital in southern France. This partnership leverages the SOPHiA DDM Platform to enhance pharmacogenomics research, aimed at understanding the impact of genetic profiles on medication efficacy. This collaboration underscores the growing importance of precision medicine, providing CHU de Nîmes with advanced tools for drug response research, thereby fostering individualized treatment plans for the French patient populace.

Diatech Pharmacogenetics Announces New Collaboration to Advance Precision Testing in Oncology

Diatech Pharmacogenetics, a European entity in precision medicine, has embarked on a pivotal collaboration with Janssen Pharmaceutica NV to revolutionize patient care in bladder cancer through enhanced access to precision medicine. Specializing in the research and manufacture of In Vitro Diagnostic (IVD) tests across oncology, Diatech is at the forefront of developing innovative diagnostic tools that identify critical gene alterations, thereby facilitating the administration of targeted therapies. Amidst a growing landscape of targeted drug development aimed at managing and potentially curing various cancers, Diatech's initiative focuses on creating a novel molecular test tailored for bladder cancer

MyRx launches to provide virtual pharmacogenetic testing consultations

The innovative MyRx service, launched by the University of Florida College of Pharmacy, offers a groundbreaking approach for patients to interpret their pharmacogenetic test outcomes, enhancing medication efficacy significantly. MyRx simplifies the complexity of pharmacogenetic testing, which is crucial for tailoring treatment plans for issues such as depression, anxiety, pain management, and cardiovascular health.

Key Company Profiles

The report delves into recent significant developments in the Pharmacogenomics Market, highlighting leading vendors and their innovative profiles. These include Admera Health, Agena Biosciences Inc. by Mesa Laboratories, Inc., BiogeniQ Inc., Castle Biosciences, Inc., CENTOGENE N.V., Coriell Life Sciences, Diatech Pharmacogenetics, Dynamic DNA Laboratorie, Empire Genomics by Biocare Medical, Exceltox Laboratories, Genelex Corporation by Invitae, Genetworx, Genomind, GenXys, Gravity Diagnostics, Illunima Inc., Integra Laboratories, Kailos Genetics by healthŌme, Myriad Genetics Inc., OneOme LLC, Personalis Inc., Phamatech Inc. by Caris Life Sciences, Quest Diagnostics, Thermo Fisher Scientific Inc., and ViennaLab Diagnostics GmbH by BioVendor Group.

This research report offers invaluable insights into various crucial aspects of the Pharmacogenomics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of chronic diseases and demand for precision medicine
5.1.1.2. Increasing investments for healthcare infrastructures
5.1.1.3. Technological advancements associated with molecular diagnostics procedure
5.1.2. Restraints
5.1.2.1. High costs associated with research and development proficiencies
5.1.3. Opportunities
5.1.3.1. Emerging trend of personalized medicines and direct-to-consumer genetic testing services
5.1.3.2. Rising investment in R&D activities to improve pharmacogenomics
5.1.4. Challenges
5.1.4.1. Dearth of awareness and required infrastructural facilities
5.2. Market Segmentation Analysis
5.2.1. Technology: Advances in Polymerase Chain Reaction technique
5.2.2. Application: Diverse applications of pharmacogenomics across industries
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Pharmacogenomics Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Kits & Reagents
6.4. Services
7. Pharmacogenomics Market, by Technology
7.1. Introduction
7.2. DNA Sequencing
7.3. Electrophoresis
7.4. Mass Spectrometry
7.5. Microarray
7.6. Polymerase Chain Reaction
8. Pharmacogenomics Market, by Indication
8.1. Introduction
8.2. Neurology
8.3. Oncology
8.4. Pain Management
9. Pharmacogenomics Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics Labs
9.3. Clinical Research & Drug Discovery
9.4. Personalized Medicine
10. Americas Pharmacogenomics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Pharmacogenomics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Pharmacogenomics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. SOPHiA GENETICS Announces Expansion of Work with CHU de Nîmes
13.3.2. Diatech Pharmacogenetics Announces New Collaboration to Advance Precision Testing in Oncology
13.3.3. MyRx launches to provide virtual pharmacogenetic testing consultations
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. PHARMACOGENOMICS MARKET RESEARCH PROCESS
FIGURE 2. PHARMACOGENOMICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PHARMACOGENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PHARMACOGENOMICS MARKET DYNAMICS
FIGURE 7. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. PHARMACOGENOMICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. PHARMACOGENOMICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PHARMACOGENOMICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PHARMACOGENOMICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL PHARMACOGENOMICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY MICROARRAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS LABS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS LABS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY CLINICAL RESEARCH & DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY CLINICAL RESEARCH & DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. CANADA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. CANADA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. CANADA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 72. CANADA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 73. CANADA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 74. CANADA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 75. CANADA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. CANADA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. MEXICO PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. MEXICO PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. MEXICO PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 80. MEXICO PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 81. MEXICO PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 82. MEXICO PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 83. MEXICO PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. MEXICO PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES PHARMACOGENOMICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. CHINA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. CHINA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. CHINA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 116. CHINA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 117. CHINA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 118. CHINA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 119. CHINA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. CHINA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. INDIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 122. INDIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 123. INDIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 124. INDIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 125. INDIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 126. INDIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 127. INDIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. INDIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. JAPAN PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. JAPAN PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. JAPAN PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 140. JAPAN PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 141. JAPAN PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 142. JAPAN PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 143. JAPAN PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. JAPAN PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. THAILAND PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 186. THAILAND PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 187. THAILAND PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 188. THAILAND PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 189. THAILAND PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 190. THAILAND PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 191. THAILAND PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. THAILAND PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 211. DENMARK PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. DENMARK PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. DENMARK PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 214. DENMARK PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 215. DENMARK PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 216. DENMARK PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 217. DENMARK PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. DENMARK PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. EGYPT PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. EGYPT PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. EGYPT PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. EGYPT PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. EGYPT PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 224. EGYPT PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 225. EGYPT PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 226. EGYPT PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 227. FINLAND PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 228. FINLAND PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 229. FINLAND PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 230. FINLAND PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 231. FINLAND PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 232. FINLAND PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 233. FINLAND PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. FINLAND PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. FRANCE PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. FRANCE PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. FRANCE PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 238. FRANCE PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 239. FRANCE PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 240. FRANCE PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 241. FRANCE PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. FRANCE PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. GERMANY PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. GERMANY PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. GERMANY PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 246. GERMANY PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 247. GERMANY PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 248. GERMANY PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 249. GERMANY PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 250. GERMANY PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. ITALY PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. ITALY PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. ITALY PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 262. ITALY PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 263. ITALY PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 264. ITALY PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 265. ITALY PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. ITALY PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. NORWAY PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. NORWAY PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. NORWAY PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 286. NORWAY PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 287. NORWAY PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 288. NORWAY PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 289. NORWAY PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. NORWAY PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. POLAND PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 292. POLAND PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 293. POLAND PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 294. POLAND PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 295. POLAND PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 296. POLAND PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 297. POLAND PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. POLAND PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. QATAR PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 300. QATAR PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 301. QATAR PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 302. QATAR PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 303. QATAR PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 304. QATAR PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 305. QATAR PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 306. QATAR PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. SPAIN PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 332. SPAIN PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 333. SPAIN PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 334. SPAIN PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 335. SPAIN PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 336. SPAIN PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 337. SPAIN PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 338. SPAIN PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 340. SWEDEN PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 341. SWEDEN PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 342. SWEDEN PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 343. SWEDEN PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 344. SWEDEN PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 345. SWEDEN PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 346. SWEDEN PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 347. SWITZERLAND PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 348. SWITZERLAND PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 349. SWITZERLAND PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 350. SWITZERLAND PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 351. SWITZERLAND PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 352. SWITZERLAND PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 353. SWITZERLAND PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 354. SWITZERLAND PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 355. TURKEY PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 356. TURKEY PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 357. TURKEY PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 358. TURKEY PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 359. TURKEY PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 360. TURKEY PHARMACOGENOMICS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 361. TURKEY PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 362. TURKEY PHARMACOGENOMICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 364. UNITED ARAB EMIRATES PHARMACOGENOMICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 365. UNITED ARAB EMIRATES PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 366. UNITED ARAB EMIRATES PHARMACOGENOMICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 367. UNITED ARAB EMIRATES PHARMACOGENOM

Companies Mentioned

  • Admera Health
  • Agena Biosciences Inc. by Mesa Laboratories, Inc.
  • BiogeniQ Inc.
  • Castle Biosciences, Inc.
  • CENTOGENE N.V.
  • Coriell Life Sciences
  • Diatech Pharmacogenetics
  • Dynamic DNA Laboratorie
  • Empire Genomics by Biocare Medical
  • Exceltox Laboratories
  • Genelex Corporation by Invitae
  • Genetworx
  • Genomind
  • GenXys
  • Gravity Diagnostics
  • Illunima Inc.
  • Integra Laboratories
  • Kailos Genetics by healthŌme
  • Myriad Genetics Inc.
  • OneOme LLC
  • Personalis Inc.
  • Phamatech Inc. by Caris Life Sciences
  • Quest Diagnostics
  • Thermo Fisher Scientific Inc.
  • ViennaLab Diagnostics GmbH by BioVendor Group

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.2 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Pharmacogenomics Technology Market Size, Share & Trends Analysis Report By Therapeutic Area, By Technology (PCR, In-situ Hybridization, Immunohistochemistry, Sequencing, Others), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Pharmacogenomics Technology Market Size, Share & Trends Analysis Report By Therapeutic Area, By Technology (PCR, In-situ Hybridization, Immunohistochemistry, Sequencing, Others), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Pharmacogenomics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Pharmacogenomics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Global Pharmacogenomics Market by Offering (Instrument, Consumables, Software), Technology (PCR, Sequencing, Microarray), Application (Oncology, Mental Health, Cardiology, Neurology, Infectious Disease), End User (Hospitals, Academic) - Forecast to 2031 - Product Image

Global Pharmacogenomics Market by Offering (Instrument, Consumables, Software), Technology (PCR, Sequencing, Microarray), Application (Oncology, Mental Health, Cardiology, Neurology, Infectious Disease), End User (Hospitals, Academic) - Forecast to 2031

  • Report
  • 210 Pages
  • Global
From
Global Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Forecast to 2028 - Product Image

Global Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Forecast to 2028

  • Report
  • 381 Pages
  • Global
From
Pharmacogenomics Technology Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Pharmacogenomics Technology Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.